Geoffrey Potter's Anticounterfeit Practice Has the Air of an International Detective Thriller

Jeffrey Potter’s anti‑counterfeiting practice shows why civil litigation has become the fastest weapon against dangerous fakes. By filing ex parte motions, plaintiffs secure seizure orders, asset‑freeze orders and temporary restraining orders before the defendant even sees the complaint. This pre‑emptive discovery lets U.S. Marshals confiscate counterfeit goods, manufacturing equipment, phone records and computers, effectively shutting down a scheme at the outset. Because the Department of Justice can only bring a handful of criminal cases each year, brand owners rely on these swift civil actions to protect patients, preserve brand integrity, and recover losses.

The practice’s focus on pharmaceuticals and medical devices highlights the unique hazards of diverted product. Counterfeit Surgicel implants, discovered after a Kentucky brain surgeon flagged a faulty device, led investigators to a home workshop in India and a downstream distributor in China. By copying WhatsApp chats and executing international seizure orders, Potter’s team exposed a gray‑market network that supplied hospitals with sub‑standard, sometimes bacterially contaminated, devices. The case underscores how low‑cost, non‑critical items can still pose lethal risks when purchasing departments chase the cheapest price without understanding the full supply chain. Education campaigns, such as Ethicon’s internal film, aim to stop clerical buyers from inadvertently endangering patients.

Financially, anti‑counterfeiting statutes provide powerful leverage. Plaintiffs can claim statutory damages up to $2 million per trademark, meaning a single counterfeit bearing five trademarks could generate a $10 million award without proving actual loss. Over three decades, Potter’s team has recovered hundreds of millions for clients, while also deterring future schemes. Emerging trends include the theft of free medication from low‑income patients, which is then resold on the gray market, threatening public health and creating new litigation fronts. As counterfeit operations become more sophisticated and globally coordinated, proactive brand‑protection strategies, cross‑border cooperation, and continuous staff training will be essential to stay ahead of the threat.